X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14) 14
index medicus (12) 12
female (11) 11
male (10) 10
middle aged (10) 10
aged (8) 8
adult (7) 7
anticoagulants (7) 7
double-blind method (7) 7
warfarin (7) 7
care and treatment (6) 6
drug therapy (6) 6
medicine, general & internal (6) 6
thromboembolism (6) 6
abridged index medicus (5) 5
patients (5) 5
prevention (5) 5
stroke (5) 5
warfarin - therapeutic use (5) 5
aged, 80 and over (4) 4
anticoagulants - therapeutic use (4) 4
dermatology (4) 4
follow-up studies (4) 4
hemorrhage - chemically induced (4) 4
medical research (4) 4
pyridines - adverse effects (4) 4
surgery (4) 4
warfarin - adverse effects (4) 4
analysis (3) 3
anticoagulants - adverse effects (3) 3
atrial fibrillation (3) 3
atrial-fibrillation (3) 3
benzimidazoles (3) 3
benzimidazoles - adverse effects (3) 3
benzimidazoles - therapeutic use (3) 3
bleeding (3) 3
cardiac arrhythmia (3) 3
clinical trials (3) 3
dabigatran (3) 3
health risk assessment (3) 3
hematology, oncology and palliative medicine (3) 3
hemorrhage (3) 3
heparin (3) 3
international normalized ratio (3) 3
kaplan-meier estimate (3) 3
life sciences (3) 3
management (3) 3
medicine & public health (3) 3
medicine, experimental (3) 3
metastasis (3) 3
oncology (3) 3
oral anticoagulant-therapy (3) 3
pyridines (3) 3
pyridines - administration & dosage (3) 3
risk (3) 3
risk factors (3) 3
skin (3) 3
studies (3) 3
survival rate (3) 3
venous thromboembolism (3) 3
young adult (3) 3
[ sdv ] life sciences [q-bio] (2) 2
adolescent (2) 2
anticoagulants - administration & dosage (2) 2
antineoplastic agents (2) 2
antineoplastic agents - adverse effects (2) 2
antithrombotic therapy (2) 2
article (2) 2
aspirin (2) 2
atrial fibrillation - drug therapy (2) 2
basal cell carcinoma (2) 2
biphenyl compounds - administration & dosage (2) 2
biphenyl compounds - adverse effects (2) 2
cancer (2) 2
carcinoma, basal cell - drug therapy (2) 2
dosage and administration (2) 2
drug administration schedule (2) 2
drug dosages (2) 2
efficacy (2) 2
embolism (2) 2
embolisms (2) 2
epidemiology (2) 2
etexilate (2) 2
fibrillation (2) 2
heart attacks (2) 2
malignant-melanoma (2) 2
medical colleges (2) 2
melanoma (2) 2
molecular-weight heparin (2) 2
neoplasm recurrence, local - pathology (2) 2
neoplasm recurrence, local - surgery (2) 2
open-label (2) 2
original paper (2) 2
patient outcomes (2) 2
pharmacology & pharmacy (2) 2
proteins (2) 2
pyridines - therapeutic use (2) 2
randomized-trial (2) 2
recurrence (2) 2
resistance (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 6, pp. 716 - 728
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2016, Volume 75, Issue 1, pp. 113 - 125.e5
Background The hedgehog pathway inhibitor sonidegib demonstrated meaningful tumor shrinkage in more than 90% of patients with locally advanced basal cell... 
Dermatology | Basal Cell Carcinoma Outcomes with LDE225 Treatment study | hedgehog pathway inhibitor | sonidegib | locally advanced basal cell carcinoma | metastatic basal cell carcinoma | advanced basal cell carcinoma | Locally advanced basal cell carcinoma | Advanced basal cell carcinoma | Metastatic basal cell carcinoma | Sonidegib | Hedgehog pathway inhibitor | HEDGEHOG PATHWAY | MULTICENTER | VISMODEGIB | MANAGEMENT | EFFICACY | GUIDELINES | OPEN-LABEL | DERMATOLOGY | DOSE-ESCALATION | UPDATE | INHIBITOR | Skin Neoplasms - drug therapy | Humans | Middle Aged | Carcinoma, Basal Cell - secondary | Biphenyl Compounds - adverse effects | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Biphenyl Compounds - therapeutic use | Young Adult | Pyridines - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Smoothened Receptor - antagonists & inhibitors | Pyridines - therapeutic use | Skin Neoplasms - pathology | Pyridines - administration & dosage | Double-Blind Method | Survival Rate | Disease Progression | Biphenyl Compounds - administration & dosage | Carcinoma, Basal Cell - drug therapy | Aged | Medical research | Care and treatment | Basal cell carcinoma | Analysis | Patient outcomes | Corn | Medicine, Experimental | Skin | Metastasis | Drug therapy | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 757 - 767
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 12, pp. 1139 - 1151
Journal Article